Transforming Modern AML Care: Clinical Solutions With Novel Agents for Diverse Patient Populations

Transforming Modern AML Care: Clinical Solutions With Novel Agents for Diverse Patient Populations

How novel agents & individualized treatment approaches are improving outcomes in patients with AMLПодробнее

How novel agents & individualized treatment approaches are improving outcomes in patients with AML

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical PathwaysПодробнее

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

Session highlights: transforming AML treatment and building on new approachesПодробнее

Session highlights: transforming AML treatment and building on new approaches

Seizing Opportunity in AML: Realizing the Potential of Novel Tx in Diverse Patient PopulationsПодробнее

Seizing Opportunity in AML: Realizing the Potential of Novel Tx in Diverse Patient Populations

Advances and unanswered questions in AML: novel agents, MRD assessment, and immunotherapyПодробнее

Advances and unanswered questions in AML: novel agents, MRD assessment, and immunotherapy

Promising novel agents in AML: menin inhibitorsПодробнее

Promising novel agents in AML: menin inhibitors

Novel Therapies in Myeloid NeoplasmsПодробнее

Novel Therapies in Myeloid Neoplasms

Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCTПодробнее

Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT

Role of FLT3 Inhibitors and Other Novel Agents in AMLПодробнее

Role of FLT3 Inhibitors and Other Novel Agents in AML

Advances in AML Care: Highlights From Recent ScienceПодробнее

Advances in AML Care: Highlights From Recent Science

AML Treatment Challenges Who, When, and HowПодробнее

AML Treatment Challenges Who, When, and How

Modern AML Therapy: Precision and Potent TherapeuticsПодробнее

Modern AML Therapy: Precision and Potent Therapeutics

Advancements in CML: improving treatment-free remission and novel agentsПодробнее

Advancements in CML: improving treatment-free remission and novel agents

How the AML treatment landscape is changing with the introduction of novel targeted agentsПодробнее

How the AML treatment landscape is changing with the introduction of novel targeted agents

Clinical trials aiming to reduce the toxicity of novel agents in AMLПодробнее

Clinical trials aiming to reduce the toxicity of novel agents in AML

Expert Overview | AML Treatment Options and Phases of TherapyПодробнее

Expert Overview | AML Treatment Options and Phases of Therapy

Novel treatment combinations in AML: what’s to come?Подробнее

Novel treatment combinations in AML: what’s to come?

AML–Improving outcomes w incorporation of Novel agents | Dr. Monzr M. Al Malki (16 Feb 2024)Подробнее

AML–Improving outcomes w incorporation of Novel agents | Dr. Monzr M. Al Malki (16 Feb 2024)

Новости